Published in Vaccine Weekly, September 2nd, 2009
"Recently, we developed a novel DNA vaccine that generates neutralizing endogenous anti-MIF antibodies. This study explores the preventive and therapeutic effects of this MIF-DNA vaccine in mouse models of AD. Two different AD model mice (DS-Nh and NC/Nga) received MIF-DNA vaccination to analyze preventive and therapeutic effects, as assessed by clinical skin scores, histologic findings, and serum IgE levels. In murine models of AD,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2009-09-02)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.